Article Information
History
- September 24, 2021.
Article Versions
- You are currently viewing Version 1 of this article (September 24, 2021 - 21:05).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Cassandra Morrison, PhD1,*,
- Mahsa Dadar, PhD1,2,
- Sylvia Villeneuve, PhD1,3,4,5,
- D. Louis Collins, PhD1,5,
- for Alzheimer’s Disease Neuroimaging Initiative‡
- 1McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
- 2Department of Radiology and Nuclear Medicine, Faculty of Medicine, Laval University
- 3Department of Psychiatry, McGill University, H3A 1A1, Montreal, Quebec, Canada
- 4Douglas Mental Health University Institute, Studies on Prevention of Alzheimer’s Disease (StoP-AD) Centre, H4H 1R3, Montreal, Quebec, Canada
- 5Department of Neurology and Neurosurgery, McGill University, H3A 2B4, Montreal, Quebec, Canada
- ↵*Corresponding author:
Cassandra Morrison, Montreal Neurological Institute, 3801 University Street, Montreal QC, H3A 2B4 email: cassandra.morrison{at}mail.mcgill.ca
Posted September 24, 2021.
White matter hyperintensities may be an early marker for age-related cognitive decline in the ADNI cohort
